Tag: Cancer: Cervical
Tisotumab Vedotin Efficacious for Recurrent Cervical Cancer
Second- or third-line treatment yields significantly greater efficacy than chemotherapy, including longer overall survival
Survival Improves With Open Hysterectomy for Cervical Cancer
Lower rate of disease-free survival and overall survival seen for minimally invasive versus open hysterectomy
Past-Year Pap Testing Rates Were Lower in 2022 Than 2019
Unadjusted past-year testing rates were significantly lower among rural than urban residents in 2022
FDA Approves First Self-Test Collection Kit for HPV
AACR: At-Home HPV Testing Boosts Cervical Cancer Screening Participation
Combining self-sampling with phone-based patient navigation further increases screening participation
New Federal Rule Means Hospitals Need Written Consent for Pelvic, Prostate Exams
Simple Hysterectomy Not Inferior for Pelvic Recurrence in Cervical Cancer
Simple hysterectomy not inferior to radical hysterectomy for patients with low-risk cervical cancer
Incidence of Cervical Cancer Has Increased in Recent Years
Increase seen among non-Hispanic White women living in low-income counties, with significant increase in distant-stage cervical cancer
Atezolizumab Plus Standard Care Improves Survival in Advanced Cervical Cancer
Median progression-free and overall survival significantly longer with standard therapy plus atezolizumab
Direct-Mail Self-Sampling Increases Uptake of Cervical Cancer Screening
Opt-in approach with option to request a self-sampling kit minimally increases screening uptake
